Accelerating 3D printing of pharmaceutical products using machine learning
Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical devices. However, it may be burdened by the lengthy empirical process of formulation development. Active research in pharmaceutical 3DP has led to...
Saved in:
| Published in | International journal of pharmaceutics: X Vol. 4; p. 100120 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
01.12.2022
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical devices. However, it may be burdened by the lengthy empirical process of formulation development. Active research in pharmaceutical 3DP has led to a wealth of data that machine learning could utilize to provide predictions of formulation outcomes. A balanced dataset is critical for optimal predictive performance of machine learning (ML) models, but data available from published literature often only include positive results. In this study, in-house and literature-mined data on hot melt extrusion (HME) and fused deposition modeling (FDM) 3DP formulations were combined to give a more balanced dataset of 1594 formulations. The optimized ML models predicted the printability and filament mechanical characteristics with an accuracy of 84%, and predicted HME and FDM processing temperatures with a mean absolute error of 5.5 °C and 8.4 °C, respectively. The performance of these ML models was better than previous iterations with a smaller and a more imbalanced dataset, highlighting the importance of providing a structured and heterogeneous dataset for optimal ML performance. The optimized models were integrated in an updated web-application, M3DISEEN, that provides predictions on filament characteristics, printability, HME and FDM processing temperatures, and drug release profiles (https://m3diseen.com/predictionsFDM/). By simulating the workflow of preparing FDM-printed pharmaceutical products, the web-application expedites the otherwise empirical process of formulation development, facilitating higher pharmaceutical 3DP research throughput.
[Display omitted] |
|---|---|
| AbstractList | Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical devices. However, it may be burdened by the lengthy empirical process of formulation development. Active research in pharmaceutical 3DP has led to a wealth of data that machine learning could utilize to provide predictions of formulation outcomes. A balanced dataset is critical for optimal predictive performance of machine learning (ML) models, but data available from published literature often only include positive results. In this study, in-house and literature-mined data on hot melt extrusion (HME) and fused deposition modeling (FDM) 3DP formulations were combined to give a more balanced dataset of 1594 formulations. The optimized ML models predicted the printability and filament mechanical characteristics with an accuracy of 84%, and predicted HME and FDM processing temperatures with a mean absolute error of 5.5 °C and 8.4 °C, respectively. The performance of these ML models was better than previous iterations with a smaller and a more imbalanced dataset, highlighting the importance of providing a structured and heterogeneous dataset for optimal ML performance. The optimized models were integrated in an updated web-application, M3DISEEN, that provides predictions on filament characteristics, printability, HME and FDM processing temperatures, and drug release profiles (https://m3diseen.com/predictionsFDM/). By simulating the workflow of preparing FDM-printed pharmaceutical products, the web-application expedites the otherwise empirical process of formulation development, facilitating higher pharmaceutical 3DP research throughput.Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical devices. However, it may be burdened by the lengthy empirical process of formulation development. Active research in pharmaceutical 3DP has led to a wealth of data that machine learning could utilize to provide predictions of formulation outcomes. A balanced dataset is critical for optimal predictive performance of machine learning (ML) models, but data available from published literature often only include positive results. In this study, in-house and literature-mined data on hot melt extrusion (HME) and fused deposition modeling (FDM) 3DP formulations were combined to give a more balanced dataset of 1594 formulations. The optimized ML models predicted the printability and filament mechanical characteristics with an accuracy of 84%, and predicted HME and FDM processing temperatures with a mean absolute error of 5.5 °C and 8.4 °C, respectively. The performance of these ML models was better than previous iterations with a smaller and a more imbalanced dataset, highlighting the importance of providing a structured and heterogeneous dataset for optimal ML performance. The optimized models were integrated in an updated web-application, M3DISEEN, that provides predictions on filament characteristics, printability, HME and FDM processing temperatures, and drug release profiles (https://m3diseen.com/predictionsFDM/). By simulating the workflow of preparing FDM-printed pharmaceutical products, the web-application expedites the otherwise empirical process of formulation development, facilitating higher pharmaceutical 3DP research throughput. Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical devices. However, it may be burdened by the lengthy empirical process of formulation development. Active research in pharmaceutical 3DP has led to a wealth of data that machine learning could utilize to provide predictions of formulation outcomes. A balanced dataset is critical for optimal predictive performance of machine learning (ML) models, but data available from published literature often only include positive results. In this study, in-house and literature-mined data on hot melt extrusion (HME) and fused deposition modeling (FDM) 3DP formulations were combined to give a more balanced dataset of 1594 formulations. The optimized ML models predicted the printability and filament mechanical characteristics with an accuracy of 84%, and predicted HME and FDM processing temperatures with a mean absolute error of 5.5 °C and 8.4 °C, respectively. The performance of these ML models was better than previous iterations with a smaller and a more imbalanced dataset, highlighting the importance of providing a structured and heterogeneous dataset for optimal ML performance. The optimized models were integrated in an updated web-application, M3DISEEN, that provides predictions on filament characteristics, printability, HME and FDM processing temperatures, and drug release profiles (https://m3diseen.com/predictionsFDM/). By simulating the workflow of preparing FDM-printed pharmaceutical products, the web-application expedites the otherwise empirical process of formulation development, facilitating higher pharmaceutical 3DP research throughput. [Display omitted] Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical devices. However, it may be burdened by the lengthy empirical process of formulation development. Active research in pharmaceutical 3DP has led to a wealth of data that machine learning could utilize to provide predictions of formulation outcomes. A balanced dataset is critical for optimal predictive performance of machine learning (ML) models, but data available from published literature often only include positive results. In this study, in-house and literature-mined data on hot melt extrusion (HME) and fused deposition modeling (FDM) 3DP formulations were combined to give a more balanced dataset of 1594 formulations. The optimized ML models predicted the printability and filament mechanical characteristics with an accuracy of 84%, and predicted HME and FDM processing temperatures with a mean absolute error of 5.5 °C and 8.4 °C, respectively. The performance of these ML models was better than previous iterations with a smaller and a more imbalanced dataset, highlighting the importance of providing a structured and heterogeneous dataset for optimal ML performance. The optimized models were integrated in an updated web-application, M3DISEEN , that provides predictions on filament characteristics, printability, HME and FDM processing temperatures, and drug release profiles ( https://m3diseen.com/predictionsFDM/ ). By simulating the workflow of preparing FDM-printed pharmaceutical products, the web-application expedites the otherwise empirical process of formulation development, facilitating higher pharmaceutical 3DP research throughput. Unlabelled Image Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical devices. However, it may be burdened by the lengthy empirical process of formulation development. Active research in pharmaceutical 3DP has led to a wealth of data that machine learning could utilize to provide predictions of formulation outcomes. A balanced dataset is critical for optimal predictive performance of machine learning (ML) models, but data available from published literature often only include positive results. In this study, in-house and literature-mined data on hot melt extrusion (HME) and fused deposition modeling (FDM) 3DP formulations were combined to give a more balanced dataset of 1594 formulations. The optimized ML models predicted the printability and filament mechanical characteristics with an accuracy of 84%, and predicted HME and FDM processing temperatures with a mean absolute error of 5.5 °C and 8.4 °C, respectively. The performance of these ML models was better than previous iterations with a smaller and a more imbalanced dataset, highlighting the importance of providing a structured and heterogeneous dataset for optimal ML performance. The optimized models were integrated in an updated web-application, M3DISEEN, that provides predictions on filament characteristics, printability, HME and FDM processing temperatures, and drug release profiles (https://m3diseen.com/predictionsFDM/). By simulating the workflow of preparing FDM-printed pharmaceutical products, the web-application expedites the otherwise empirical process of formulation development, facilitating higher pharmaceutical 3DP research throughput. |
| ArticleNumber | 100120 |
| Author | Ong, Jun Jie Castro, Brais Muñiz Gaisford, Simon Cabalar, Pedro Basit, Abdul W. Pérez, Gilberto Goyanes, Alvaro |
| Author_xml | – sequence: 1 givenname: Jun Jie surname: Ong fullname: Ong, Jun Jie organization: Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK – sequence: 2 givenname: Brais Muñiz surname: Castro fullname: Castro, Brais Muñiz organization: IRLab, CITIC Research Center, Department of Computer Science, University of A Coruña, Spain – sequence: 3 givenname: Simon surname: Gaisford fullname: Gaisford, Simon organization: Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK – sequence: 4 givenname: Pedro surname: Cabalar fullname: Cabalar, Pedro organization: IRLab, Department of Computer Science, University of A Coruña, Spain – sequence: 5 givenname: Abdul W. surname: Basit fullname: Basit, Abdul W. email: a.basit@ucl.ac.uk organization: Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK – sequence: 6 givenname: Gilberto surname: Pérez fullname: Pérez, Gilberto email: gilberto.pvega@udc.es organization: IRLab, CITIC Research Center, Department of Computer Science, University of A Coruña, Spain – sequence: 7 givenname: Alvaro surname: Goyanes fullname: Goyanes, Alvaro email: a.goyanes@fabrx.co.uk organization: Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK |
| BookMark | eNp9kU9v1DAQxS1UREvpF-C0Ry679f84EkKqCpSiSlx6t2btya6jrL3YSQXfHqcpEuXQk62Z9356mveWnMQUkZD3jG4YZfqy34T--GvDKed1QBmnr8gZVy1dM6Wbk3_-p-SilJ7SqmRUmPYNORWqUUpTcUa-XzmHA2YYQ9ytxOfVMYf4-E_d6riHfACH0xgcDHWV_OTGsprKLKibfYi4GhByrIN35HUHQ8GLp_ec3H_9cn_9bX334-b2-upu7WRrxrXwYuuZBpCaNdo34KQzdKtQo0PsvPKeOW-kY2g6owynWrYamOq0Ng2Kc3K7YH2C3ta4B8i_bYJgHwcp7yzkGnhAy7UGRNY1bSMkb6UxBhquvIKOKiW3lfVpYR2n7QG9wzhmGJ5Bn29i2NtderAtZ4ZzUQEfngA5_ZywjPYQSj3oABHTVGoCw6QUrTZVahapy6mUjJ11YaxnTzM5DJZROxdrezsXa-di7VJstfL_rH8Tvmj6uJiwdvEQMNviAkaHPmR0Y71WeMn-B9YNvbQ |
| CitedBy_id | crossref_primary_10_1021_acsapm_3c03102 crossref_primary_10_1021_acs_molpharmaceut_4c00144 crossref_primary_10_1177_09544119241289731 crossref_primary_10_61411_rsc202482917 crossref_primary_10_1002_adma_202310006 crossref_primary_10_1080_17425247_2024_2379943 crossref_primary_10_1089_3dp_2023_0353 crossref_primary_10_1007_s42250_024_00976_5 crossref_primary_10_1002_adhm_202401312 crossref_primary_10_2174_0113816128309717240826101647 crossref_primary_10_1080_17425247_2023_2167978 |
| Cites_doi | 10.1038/d41586-020-03348-4 10.1208/s12249-021-02094-8 10.1126/sciadv.aat2544 10.1038/s41378-021-00284-9 10.1155/2019/5340616 10.1016/j.drudis.2020.12.003 10.1007/s42979-021-00592-x 10.1016/j.ijpharm.2021.121411 10.1016/j.addr.2021.05.003 10.1016/j.apsb.2018.09.010 10.1016/j.csbj.2014.11.005 10.1093/jpp/rgab138 10.1016/j.ijpharm.2022.121553 10.3390/pharmaceutics13050759 10.1208/s12248-021-00644-3 10.3389/fphar.2020.00122 10.1016/j.ijpharm.2020.119837 10.1016/j.ijpharm.2021.121194 10.1016/j.ijpharm.2021.120501 10.1016/j.jconrel.2021.07.046 10.1016/j.ijpharm.2022.121555 10.1016/j.ijpharm.2021.121386 10.1016/j.ijpharm.2021.120315 10.1016/j.addr.2021.05.015 10.1016/j.ijpharm.2020.120049 10.1208/s12249-022-02210-2 10.1016/j.isprsjprs.2016.01.011 10.3390/pharmaceutics13122068 10.3390/ph15010069 10.1016/j.protcy.2013.12.159 10.1016/j.jconrel.2020.10.056 10.1016/j.drudis.2020.10.010 10.1038/s41746-020-00324-0 10.1016/j.ijpharm.2021.120243 10.1016/j.drudis.2017.08.010 10.1038/nbt1206-1565 10.1038/s41570-018-0058-y 10.3390/pharmaceutics13101714 10.1038/nrg3920 10.1016/j.ejmp.2021.02.006 10.1021/acs.jcim.1c01580 10.1016/j.xphs.2021.07.010 10.1016/j.ijpharm.2021.120417 10.1016/j.xphs.2021.04.013 10.1016/j.ijpharm.2021.120337 10.1016/j.matdes.2020.108940 10.1016/j.ijpharm.2019.04.017 10.1016/j.ejpb.2021.07.009 10.1016/j.xphs.2020.05.022 10.1016/j.ejps.2020.105605 10.1016/j.ijpharm.2019.118464 10.1016/j.ijpharm.2022.121663 10.1016/j.addr.2021.113923 10.1016/j.tips.2021.06.002 10.1038/s41591-021-01614-0 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors 2022 The Authors. 2022 The Authors 2022 |
| Copyright_xml | – notice: 2022 The Authors – notice: 2022 The Authors. – notice: 2022 The Authors 2022 |
| DBID | 6I. AAFTH AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1016/j.ijpx.2022.100120 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2590-1567 |
| ExternalDocumentID | oai_doaj_org_article_266aee1f79734294888a725d5af0554b PMC9218223 10_1016_j_ijpx_2022_100120 S2590156722000093 |
| GroupedDBID | 0SF 6I. AACTN AAEDW AAFTH AALRI AAXUO ABMAC AEXQZ AFTJW AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS EJD FDB GROUPED_DOAJ HYE M41 NCXOZ OK1 ROL RPM SSZ 0R~ 53G AAYWO AAYXX ADVLN AFJKZ APXCP CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c498t-3d3bd16aa46176d7ac4c80b5e6eceefd5dd1cd84c1e8f858206496a15f6687e3 |
| IEDL.DBID | DOA |
| ISSN | 2590-1567 |
| IngestDate | Wed Aug 27 01:24:07 EDT 2025 Thu Aug 21 18:06:40 EDT 2025 Fri Jul 11 07:59:20 EDT 2025 Tue Jul 01 01:08:29 EDT 2025 Thu Apr 24 23:11:00 EDT 2025 Tue Jul 25 20:57:39 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Printing medical devices and implants Artificial intelligence and digital health Material extrusion and drug delivery systems Manufacture of medicinal products Additive manufacturing of pharmaceuticals Fused filament fabrication and Fused deposition modelling 3D printed drug products and medicines |
| Language | English |
| License | This is an open access article under the CC BY license. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c498t-3d3bd16aa46176d7ac4c80b5e6eceefd5dd1cd84c1e8f858206496a15f6687e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
| OpenAccessLink | https://doaj.org/article/266aee1f79734294888a725d5af0554b |
| PMID | 35755603 |
| PQID | 2681443968 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_266aee1f79734294888a725d5af0554b pubmedcentral_primary_oai_pubmedcentral_nih_gov_9218223 proquest_miscellaneous_2681443968 crossref_citationtrail_10_1016_j_ijpx_2022_100120 crossref_primary_10_1016_j_ijpx_2022_100120 elsevier_sciencedirect_doi_10_1016_j_ijpx_2022_100120 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-12-01 |
| PublicationDateYYYYMMDD | 2022-12-01 |
| PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | International journal of pharmaceutics: X |
| PublicationYear | 2022 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Elbadawi, Gaisford, Basit (bb0090) 2021; 26 Manini, Benali, Raquez, Goole (bb0180) 2022; 618 Capel, Rimington, Lewis, Christie (bb0055) 2018; 2 Pereira, Isreb, Isreb, Forbes, Oga, Alhnan (bb0225) 2020; 9 Liang, Carmone, Brambilla, Leroux (bb0165) 2018; 4 Dumpa, Butreddy, Wang, Komanduri, Bandari, Repka (bb0075) 2021; 600 Oladeji, Mohylyuk, Jones, Andrews (bb0215) 2022; 616 Fanous, Bitar, Gold, Sobczuk, Hirsch, Ogorka, Imanidis (bb0120) 2021; 599 Paul, Sanap, Shenoy, Kalyane, Kalia, Tekade (bb0220) 2021; 26 Cailleaux, Sanchez-Ballester, Gueche, Bataille, Soulairol (bb0045) 2021; 330 Shi, Salvage, Maniruzzaman, Nokhodchi (bb0250) 2021; 597 Libbrecht, Noble (bb0170) 2015; 16 Nagy, Petra, Galata, Démuth, Borbás, Marosi, Nagy, Farkas (bb0200) 2019; 567 Henry, De Wever, Vanhoorne, De Beer, Vervaet (bb0140) 2021; 13 Nawi, Atomi, Rehman (bb0205) 2013; 11 Callaway (bb0050) 2020; 588 Martin, Domínguez-Robles, Stewart, Cornelius, Anjani, Utomo, García-Romero, Donnelly, Margariti, Lamprou, Larrañeta (bb0185) 2021; 595 American Society for Testing and Material (bb0015) 2021 Benjamens, Dhunnoo, Meskó (bb0035) 2020; 3 Belgiu, Drăguţ (bb0030) 2016; 114 Zhang, Thakkar, Kulkarni, Zhang, Lu, Maniruzzaman (bb0285) 2021; 22 Haddow, Mathew, Lamprou (bb0135) 2021 Tranová, Pyteraf, Kurek, Jamróz, Brniak, Spálovská, Loskot, Jurkiewicz, Grelska, Kramarczyk, Mužíková, Paluch, Jachowicz (bb0260) 2022; 15 Kholgh Eshkalak, Rezvani Ghomi, Dai, Choudhury, Ramakrishna (bb0150) 2020; 194 Carlier, Marquette, Peerboom, Amighi, Goole (bb0060) 2021; 597 Zhang, Tan, Han, Zhu (bb0290) 2017; 22 Fan, Li, Wang, Zhu, Wang, Cai, Li, Tian, Liu (bb0115) 2020; 11 Melocchi, Uboldi, Briatico-Vangosa, Moutaharrik, Cerea, Foppoli, Maroni, Palugan, Zema, Gazzaniga (bb0190) 2021; 13 Kourou, Exarchos, Exarchos, Karamouzis, Fotiadis (bb0160) 2015; 13 Sarker (bb0235) 2021; 2 Saviano, Bowles, Penny, Ishaq, Muwaffak, Falcone, Russo, Hilton (bb0240) 2022; 613 Eleftheriadis, Monou, Bouropoulos, Boetker, Rantanen, Jacobsen, Vizirianakis, Fatouros (bb0110) 2020; 109 Crișan, Iurian, Porfire, Rus, Bogdan, Casian, Lucacel, Turza, Porav, Tomuță (bb0070) 2022; 613 Govender, Kissi, Larsson, Tho (bb0130) 2021; 177 Rajpurkar, Chen, Banerjee, Topol (bb0230) 2022; 28 Yang, Ye, Su, Zhao, Li, Ouyang (bb0280) 2019; 9 Bogdahn, Torner, Krause, Grimm, Weitschies (bb0040) 2021; 167 Eleftheriadis, Fatouros (bb0105) 2021; 157 Kolluri, Lin, Liu, Zhang, Zhang (bb0155) 2022; 24 Wu, Park, Kamaki, Kim (bb0275) 2021; 7 Windolf, Chamberlain, Quodbach (bb0270) 2022; 616 Isreb, Baj, Wojsz, Isreb, Peak, Alhnan (bb0145) 2019; 564 Castiglioni, Rundo, Codari, Di Leo, Salvatore, Interlenghi, Gallivanone, Cozzi, D’Amico, Sardanelli (bb0065) 2021; 83 Abramov, Sun, Zeng (bb0005) 2022; 62 Seoane-Viaño, Trenfield, Basit, Goyanes (bb0245) 2021; 174 Noble (bb0210) 2006; 24 BASF (bb0025) 2022 Zhao, Wei, Niu, Li, Hu, Jiang (bb0295) 2022; 111 Wang, Yang, Chen, Chu, Yu, Wei, Zhang, Rui, Feng (bb0265) 2022; 23 Elbadawi, McCoubrey, Gavins, Ong, Goyanes, Gaisford, Basit (bb0100) 2021; 175 Arany, Papp, Zichar, Regdon, Béres, Szalóki, Kovács, Fehér, Ujhelyi, Vecsernyés, Bácskay (bb0020) 2021; 13 Thomas, Palahnuk, Amini, Akseli (bb0255) 2021; 592 Figueiredo, Fernandes, Carvalho, Pinto (bb0125) 2022; 74 Đuranović, Madžarević, Ivković, Ibrić, Cvijić (bb0080) 2021; 610 Aimar, Palermo, Innocenti (bb0010) 2019; 2019 Muñiz Castro, Elbadawi, Ong, Pollard, Song, Gaisford, Pérez, Basit, Cabalar, Goyanes (bb0195) 2021; 337 Elbadawi, McCoubrey, Gavins, Ong, Goyanes, Gaisford, Basit (bb0095) 2021; 42 Lou, Lian, Hageman (bb0175) 2021; 110 Elbadawi, Muniz Castro, Gavins, Ong, Gaisford, Perez, Basit, Cabalar, Goyanes (bb0085) 2020; 590 Crișan (10.1016/j.ijpx.2022.100120_bb0070) 2022; 613 Eleftheriadis (10.1016/j.ijpx.2022.100120_bb0105) 2021; 157 Abramov (10.1016/j.ijpx.2022.100120_bb0005) 2022; 62 Martin (10.1016/j.ijpx.2022.100120_bb0185) 2021; 595 American Society for Testing and Material (10.1016/j.ijpx.2022.100120_bb0015) 2021 Shi (10.1016/j.ijpx.2022.100120_bb0250) 2021; 597 Elbadawi (10.1016/j.ijpx.2022.100120_bb0100) 2021; 175 Castiglioni (10.1016/j.ijpx.2022.100120_bb0065) 2021; 83 Arany (10.1016/j.ijpx.2022.100120_bb0020) 2021; 13 Capel (10.1016/j.ijpx.2022.100120_bb0055) 2018; 2 Saviano (10.1016/j.ijpx.2022.100120_bb0240) 2022; 613 Muñiz Castro (10.1016/j.ijpx.2022.100120_bb0195) 2021; 337 Zhao (10.1016/j.ijpx.2022.100120_bb0295) 2022; 111 Paul (10.1016/j.ijpx.2022.100120_bb0220) 2021; 26 Manini (10.1016/j.ijpx.2022.100120_bb0180) 2022; 618 Elbadawi (10.1016/j.ijpx.2022.100120_bb0085) 2020; 590 Bogdahn (10.1016/j.ijpx.2022.100120_bb0040) 2021; 167 Kourou (10.1016/j.ijpx.2022.100120_bb0160) 2015; 13 Isreb (10.1016/j.ijpx.2022.100120_bb0145) 2019; 564 Lou (10.1016/j.ijpx.2022.100120_bb0175) 2021; 110 Pereira (10.1016/j.ijpx.2022.100120_bb0225) 2020; 9 Elbadawi (10.1016/j.ijpx.2022.100120_bb0095) 2021; 42 Wu (10.1016/j.ijpx.2022.100120_bb0275) 2021; 7 Dumpa (10.1016/j.ijpx.2022.100120_bb0075) 2021; 600 Libbrecht (10.1016/j.ijpx.2022.100120_bb0170) 2015; 16 Windolf (10.1016/j.ijpx.2022.100120_bb0270) 2022; 616 Zhang (10.1016/j.ijpx.2022.100120_bb0285) 2021; 22 Kolluri (10.1016/j.ijpx.2022.100120_bb0155) 2022; 24 Aimar (10.1016/j.ijpx.2022.100120_bb0010) 2019; 2019 Nagy (10.1016/j.ijpx.2022.100120_bb0200) 2019; 567 Fan (10.1016/j.ijpx.2022.100120_bb0115) 2020; 11 Seoane-Viaño (10.1016/j.ijpx.2022.100120_bb0245) 2021; 174 Elbadawi (10.1016/j.ijpx.2022.100120_bb0090) 2021; 26 Yang (10.1016/j.ijpx.2022.100120_bb0280) 2019; 9 Govender (10.1016/j.ijpx.2022.100120_bb0130) 2021; 177 Melocchi (10.1016/j.ijpx.2022.100120_bb0190) 2021; 13 Haddow (10.1016/j.ijpx.2022.100120_bb0135) 2021 Noble (10.1016/j.ijpx.2022.100120_bb0210) 2006; 24 Carlier (10.1016/j.ijpx.2022.100120_bb0060) 2021; 597 Benjamens (10.1016/j.ijpx.2022.100120_bb0035) 2020; 3 Oladeji (10.1016/j.ijpx.2022.100120_bb0215) 2022; 616 Rajpurkar (10.1016/j.ijpx.2022.100120_bb0230) 2022; 28 Sarker (10.1016/j.ijpx.2022.100120_bb0235) 2021; 2 BASF (10.1016/j.ijpx.2022.100120_bb0025) Kholgh Eshkalak (10.1016/j.ijpx.2022.100120_bb0150) 2020; 194 Fanous (10.1016/j.ijpx.2022.100120_bb0120) 2021; 599 Tranová (10.1016/j.ijpx.2022.100120_bb0260) 2022; 15 Zhang (10.1016/j.ijpx.2022.100120_bb0290) 2017; 22 Belgiu (10.1016/j.ijpx.2022.100120_bb0030) 2016; 114 Eleftheriadis (10.1016/j.ijpx.2022.100120_bb0110) 2020; 109 Liang (10.1016/j.ijpx.2022.100120_bb0165) 2018; 4 Wang (10.1016/j.ijpx.2022.100120_bb0265) 2022; 23 Nawi (10.1016/j.ijpx.2022.100120_bb0205) 2013; 11 Thomas (10.1016/j.ijpx.2022.100120_bb0255) 2021; 592 Callaway (10.1016/j.ijpx.2022.100120_bb0050) 2020; 588 Đuranović (10.1016/j.ijpx.2022.100120_bb0080) 2021; 610 Figueiredo (10.1016/j.ijpx.2022.100120_bb0125) 2022; 74 Henry (10.1016/j.ijpx.2022.100120_bb0140) 2021; 13 Cailleaux (10.1016/j.ijpx.2022.100120_bb0045) 2021; 330 |
| References_xml | – year: 2021 ident: bb0015 article-title: ISO/ASTM52900 Additive Manufacturing - General Principles - Fundamentals and Vocabulary – volume: 24 start-page: 19 year: 2022 ident: bb0155 article-title: Machine learning and artificial intelligence in pharmaceutical research and development: a review publication-title: AAPS J. – volume: 13 start-page: 1714 year: 2021 ident: bb0020 article-title: Manufacturing and examination of vaginal drug delivery system by FDM 3D printing publication-title: Pharmaceutics – volume: 599 year: 2021 ident: bb0120 article-title: Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution publication-title: Int. J. Pharm. – volume: 11 start-page: 32 year: 2013 end-page: 39 ident: bb0205 article-title: The effect of data pre-processing on optimized training of artificial neural networks publication-title: Procedia Technol. – volume: 564 start-page: 98 year: 2019 end-page: 105 ident: bb0145 article-title: 3D printed oral theophylline doses with innovative ‘radiator-like’ design: impact of polyethylene oxide (PEO) molecular weight publication-title: Int. J. Pharm. – volume: 3 start-page: 118 year: 2020 ident: bb0035 article-title: The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database publication-title: npj Digital Med. – volume: 26 start-page: 769 year: 2021 end-page: 777 ident: bb0090 article-title: Advanced machine-learning techniques in drug discovery publication-title: Drug Discov. Today – volume: 597 year: 2021 ident: bb0060 article-title: Development of mAb-loaded 3D-printed (FDM) implantable devices based on PLGA publication-title: Int. J. Pharm. – volume: 616 year: 2022 ident: bb0270 article-title: Dose-independent drug release from 3D printed oral medicines for patient-specific dosing to improve therapy safety publication-title: Int. J. Pharm. – volume: 9 start-page: 177 year: 2019 end-page: 185 ident: bb0280 article-title: Deep learning for in vitro prediction of pharmaceutical formulations publication-title: Acta Pharm. Sin. B – volume: 157 year: 2021 ident: bb0105 article-title: Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films publication-title: Eur. J. Pharm. Sci. – volume: 26 start-page: 80 year: 2021 end-page: 93 ident: bb0220 article-title: Artificial intelligence in drug discovery and development publication-title: Drug Discov. Today – volume: 4 year: 2018 ident: bb0165 article-title: 3D printing of a wearable personalized oral delivery device: a first-in-human study publication-title: Sci. Advances – volume: 13 start-page: 759 year: 2021 ident: bb0190 article-title: The ChronotopicTM system for pulsatile and colonic delivery of active molecules in the Era of precision medicine: feasibility by 3D printing via Fused Deposition Modeling (FDM) publication-title: Pharmaceutics – volume: 22 start-page: 258 year: 2021 ident: bb0285 article-title: Investigation of the fused deposition modeling additive manufacturing I: influence of process temperature on the quality and crystallinity of the dosage forms publication-title: AAPS PharmSciTech – volume: 42 start-page: 745 year: 2021 end-page: 757 ident: bb0095 article-title: Disrupting 3D printing of medicines with machine learning publication-title: Trends Pharmacol. Sci. – volume: 74 start-page: 67 year: 2022 end-page: 76 ident: bb0125 article-title: Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing publication-title: J. Pharm. Pharmacol. – volume: 28 start-page: 31 year: 2022 end-page: 38 ident: bb0230 article-title: AI in health and medicine publication-title: Nat. Med. – volume: 174 start-page: 553 year: 2021 end-page: 575 ident: bb0245 article-title: Translating 3D printed pharmaceuticals: from hype to real-world clinical applications publication-title: Adv. Drug Deliv. Rev. – volume: 613 year: 2022 ident: bb0240 article-title: Development and analysis of a novel loading technique for FDM 3D printed systems: Microwave-assisted impregnation of gastro-retentive PVA capsular devices publication-title: Int. J. Pharm. – volume: 330 start-page: 821 year: 2021 end-page: 841 ident: bb0045 article-title: Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines publication-title: J. Control. Release – volume: 567 year: 2019 ident: bb0200 article-title: Application of artificial neural networks for Process Analytical Technology-based dissolution testing publication-title: Int. J. Pharm. – volume: 618 year: 2022 ident: bb0180 article-title: Proof of concept of a predictive model of drug release from long-acting implants obtained by fused-deposition modeling publication-title: Int. J. Pharm. – volume: 109 start-page: 2757 year: 2020 end-page: 2766 ident: bb0110 article-title: Fabrication of Mucoadhesive Buccal films for local administration of Ketoprofen and Lidocaine Hydrochloride by Combining Fused Deposition Modeling and Inkjet Printing publication-title: J. Pharm. Sci. – volume: 23 start-page: 66 year: 2022 ident: bb0265 article-title: A strategy for the effective optimization of pharmaceutical formulations based on parameter-optimized support vector machine model publication-title: AAPS PharmSciTech – year: 2022 ident: bb0025 article-title: Meet your Virtual Pharma Assistants – volume: 600 year: 2021 ident: bb0075 article-title: 3D printing in personalized drug delivery: an overview of hot-melt extrusion-based fused deposition modeling publication-title: Int. J. Pharm. – volume: 16 start-page: 321 year: 2015 end-page: 332 ident: bb0170 article-title: Machine learning applications in genetics and genomics publication-title: Nat. Rev. Genet. – volume: 590 year: 2020 ident: bb0085 article-title: M3DISEEN: a novel machine learning approach for predicting the 3D printability of medicines publication-title: Int. J. Pharm. – volume: 83 start-page: 9 year: 2021 end-page: 24 ident: bb0065 article-title: AI applications to medical images: from machine learning to deep learning publication-title: Physica Medica – volume: 595 year: 2021 ident: bb0185 article-title: Fused deposition modelling for the development of drug loaded cardiovascular prosthesis publication-title: Int. J. Pharm. – volume: 13 start-page: 2068 year: 2021 ident: bb0140 article-title: Influence of print settings on the critical quality attributes of extrusion-based 3D-printed caplets: a quality-by-design approach publication-title: Pharmaceutics – volume: 22 start-page: 1680 year: 2017 end-page: 1685 ident: bb0290 article-title: From machine learning to deep learning: progress in machine intelligence for rational drug discovery publication-title: Drug Discov. Today – volume: 597 year: 2021 ident: bb0250 article-title: Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets publication-title: Int. J. Pharm. – volume: 175 year: 2021 ident: bb0100 article-title: Harnessing artificial intelligence for the next generation of 3D printed medicines publication-title: Adv. Drug Deliv. Rev. – volume: 616 year: 2022 ident: bb0215 article-title: 3D printing of pharmaceutical oral solid dosage forms by fused deposition: the enhancement of printability using plasticised HPMCAS publication-title: Int. J. Pharm. – year: 2021 ident: bb0135 article-title: Fused deposition modelling 3D printing proof-of-concept study for personalised inner ear therapy publication-title: J. Pharm. Pharmacol. – volume: 592 year: 2021 ident: bb0255 article-title: Data-smart machine learning methods for predicting composition-dependent Young’s modulus of pharmaceutical compacts publication-title: Int. J. Pharm. – volume: 2 start-page: 422 year: 2018 end-page: 436 ident: bb0055 article-title: 3D printing for chemical, pharmaceutical and biological applications publication-title: Nat. Rev. Chem. – volume: 110 start-page: 3150 year: 2021 end-page: 3165 ident: bb0175 article-title: Applications of machine learning in solid oral dosage form development publication-title: J. Pharm. Sci. – volume: 13 start-page: 8 year: 2015 end-page: 17 ident: bb0160 article-title: Machine learning applications in cancer prognosis and prediction publication-title: Comput. Struct. Biotechnol. J. – volume: 2019 start-page: 5340616 year: 2019 ident: bb0010 article-title: The role of 3D printing in medical applications: a state of the art publication-title: J. Healthc. Eng. – volume: 11 year: 2020 ident: bb0115 article-title: Progressive 3D printing technology and its application in medical materials publication-title: Front. Pharmacol. – volume: 7 start-page: 58 year: 2021 ident: bb0275 article-title: Optimization of the fused deposition modeling-based fabrication process for polylactic acid microneedles publication-title: Microsyst. Nanoeng. – volume: 2 start-page: 160 year: 2021 ident: bb0235 article-title: Machine learning: algorithms, real-world applications and research directions publication-title: SN Computer Sci. – volume: 167 start-page: 65 year: 2021 end-page: 72 ident: bb0040 article-title: Influence of the geometry of 3D printed solid oral dosage forms on their swallowability publication-title: Eur. J. Pharm. Biopharm. – volume: 111 start-page: 116 year: 2022 end-page: 123 ident: bb0295 article-title: 3D printed intragastric floating and sustained-release tablets with air chambers publication-title: J. Pharm. Sci. – volume: 24 start-page: 1565 year: 2006 end-page: 1567 ident: bb0210 article-title: What is a support vector machine? publication-title: Nat. Biotechnol. – volume: 177 year: 2021 ident: bb0130 article-title: Polymers in pharmaceutical additive manufacturing: a balancing act between printability and product performance publication-title: Adv. Drug Deliv. Rev. – volume: 114 start-page: 24 year: 2016 end-page: 31 ident: bb0030 article-title: Random forest in remote sensing: a review of applications and future directions publication-title: ISPRS J. Photogramm. Remote Sens. – volume: 194 year: 2020 ident: bb0150 article-title: The role of three-dimensional printing in healthcare and medicine publication-title: Mater. Des. – volume: 62 start-page: 1160 year: 2022 end-page: 1171 ident: bb0005 article-title: Emerging landscape of computational modeling in pharmaceutical development publication-title: J. Chem. Inf. Model. – volume: 337 start-page: 530 year: 2021 end-page: 545 ident: bb0195 article-title: Machine learning predicts 3D printing performance of over 900 drug delivery systems publication-title: J. Control. Release – volume: 610 year: 2021 ident: bb0080 article-title: The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed tablets through different applied strategies: in vitro-in silico assessment publication-title: Int. J. Pharm. – volume: 588 start-page: 203 year: 2020 end-page: 204 ident: bb0050 article-title: It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures publication-title: Nature. – volume: 613 year: 2022 ident: bb0070 article-title: QbD guided development of immediate release FDM-3D printed tablets with customizable API doses publication-title: Int. J. Pharm. – volume: 15 start-page: 69 year: 2022 ident: bb0260 article-title: Fused deposition modeling as a possible approach for the preparation of orodispersible tablets publication-title: Pharmaceuticals – volume: 9 year: 2020 ident: bb0225 article-title: Additive manufacturing of a point-of-care “Polypill:” fabrication of concept capsules of complex geometry with bespoke release against cardiovascular disease publication-title: Advan. Healthcare Mater. – volume: 588 start-page: 203 year: 2020 ident: 10.1016/j.ijpx.2022.100120_bb0050 article-title: It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures publication-title: Nature. doi: 10.1038/d41586-020-03348-4 – volume: 22 start-page: 258 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0285 article-title: Investigation of the fused deposition modeling additive manufacturing I: influence of process temperature on the quality and crystallinity of the dosage forms publication-title: AAPS PharmSciTech doi: 10.1208/s12249-021-02094-8 – volume: 4 year: 2018 ident: 10.1016/j.ijpx.2022.100120_bb0165 article-title: 3D printing of a wearable personalized oral delivery device: a first-in-human study publication-title: Sci. Advances doi: 10.1126/sciadv.aat2544 – volume: 7 start-page: 58 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0275 article-title: Optimization of the fused deposition modeling-based fabrication process for polylactic acid microneedles publication-title: Microsyst. Nanoeng. doi: 10.1038/s41378-021-00284-9 – volume: 2019 start-page: 5340616 year: 2019 ident: 10.1016/j.ijpx.2022.100120_bb0010 article-title: The role of 3D printing in medical applications: a state of the art publication-title: J. Healthc. Eng. doi: 10.1155/2019/5340616 – volume: 26 start-page: 769 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0090 article-title: Advanced machine-learning techniques in drug discovery publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2020.12.003 – volume: 2 start-page: 160 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0235 article-title: Machine learning: algorithms, real-world applications and research directions publication-title: SN Computer Sci. doi: 10.1007/s42979-021-00592-x – volume: 613 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0070 article-title: QbD guided development of immediate release FDM-3D printed tablets with customizable API doses publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.121411 – volume: 174 start-page: 553 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0245 article-title: Translating 3D printed pharmaceuticals: from hype to real-world clinical applications publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2021.05.003 – volume: 9 start-page: 177 year: 2019 ident: 10.1016/j.ijpx.2022.100120_bb0280 article-title: Deep learning for in vitro prediction of pharmaceutical formulations publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2018.09.010 – volume: 13 start-page: 8 year: 2015 ident: 10.1016/j.ijpx.2022.100120_bb0160 article-title: Machine learning applications in cancer prognosis and prediction publication-title: Comput. Struct. Biotechnol. J. doi: 10.1016/j.csbj.2014.11.005 – volume: 74 start-page: 67 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0125 article-title: Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing publication-title: J. Pharm. Pharmacol. doi: 10.1093/jpp/rgab138 – volume: 616 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0215 article-title: 3D printing of pharmaceutical oral solid dosage forms by fused deposition: the enhancement of printability using plasticised HPMCAS publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2022.121553 – volume: 13 start-page: 759 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0190 article-title: The ChronotopicTM system for pulsatile and colonic delivery of active molecules in the Era of precision medicine: feasibility by 3D printing via Fused Deposition Modeling (FDM) publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13050759 – volume: 24 start-page: 19 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0155 article-title: Machine learning and artificial intelligence in pharmaceutical research and development: a review publication-title: AAPS J. doi: 10.1208/s12248-021-00644-3 – volume: 11 year: 2020 ident: 10.1016/j.ijpx.2022.100120_bb0115 article-title: Progressive 3D printing technology and its application in medical materials publication-title: Front. Pharmacol. doi: 10.3389/fphar.2020.00122 – volume: 590 year: 2020 ident: 10.1016/j.ijpx.2022.100120_bb0085 article-title: M3DISEEN: a novel machine learning approach for predicting the 3D printability of medicines publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2020.119837 – volume: 610 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0080 article-title: The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed tablets through different applied strategies: in vitro-in silico assessment publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.121194 – volume: 600 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0075 article-title: 3D printing in personalized drug delivery: an overview of hot-melt extrusion-based fused deposition modeling publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.120501 – volume: 337 start-page: 530 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0195 article-title: Machine learning predicts 3D printing performance of over 900 drug delivery systems publication-title: J. Control. Release doi: 10.1016/j.jconrel.2021.07.046 – volume: 616 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0270 article-title: Dose-independent drug release from 3D printed oral medicines for patient-specific dosing to improve therapy safety publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2022.121555 – volume: 613 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0240 article-title: Development and analysis of a novel loading technique for FDM 3D printed systems: Microwave-assisted impregnation of gastro-retentive PVA capsular devices publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.121386 – volume: 597 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0250 article-title: Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.120315 – volume: 175 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0100 article-title: Harnessing artificial intelligence for the next generation of 3D printed medicines publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2021.05.015 – volume: 592 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0255 article-title: Data-smart machine learning methods for predicting composition-dependent Young’s modulus of pharmaceutical compacts publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2020.120049 – volume: 23 start-page: 66 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0265 article-title: A strategy for the effective optimization of pharmaceutical formulations based on parameter-optimized support vector machine model publication-title: AAPS PharmSciTech doi: 10.1208/s12249-022-02210-2 – volume: 114 start-page: 24 year: 2016 ident: 10.1016/j.ijpx.2022.100120_bb0030 article-title: Random forest in remote sensing: a review of applications and future directions publication-title: ISPRS J. Photogramm. Remote Sens. doi: 10.1016/j.isprsjprs.2016.01.011 – ident: 10.1016/j.ijpx.2022.100120_bb0025 – volume: 13 start-page: 2068 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0140 article-title: Influence of print settings on the critical quality attributes of extrusion-based 3D-printed caplets: a quality-by-design approach publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13122068 – volume: 15 start-page: 69 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0260 article-title: Fused deposition modeling as a possible approach for the preparation of orodispersible tablets publication-title: Pharmaceuticals doi: 10.3390/ph15010069 – volume: 11 start-page: 32 year: 2013 ident: 10.1016/j.ijpx.2022.100120_bb0205 article-title: The effect of data pre-processing on optimized training of artificial neural networks publication-title: Procedia Technol. doi: 10.1016/j.protcy.2013.12.159 – volume: 330 start-page: 821 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0045 article-title: Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines publication-title: J. Control. Release doi: 10.1016/j.jconrel.2020.10.056 – volume: 26 start-page: 80 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0220 article-title: Artificial intelligence in drug discovery and development publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2020.10.010 – volume: 3 start-page: 118 year: 2020 ident: 10.1016/j.ijpx.2022.100120_bb0035 article-title: The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database publication-title: npj Digital Med. doi: 10.1038/s41746-020-00324-0 – volume: 595 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0185 article-title: Fused deposition modelling for the development of drug loaded cardiovascular prosthesis publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.120243 – volume: 22 start-page: 1680 year: 2017 ident: 10.1016/j.ijpx.2022.100120_bb0290 article-title: From machine learning to deep learning: progress in machine intelligence for rational drug discovery publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2017.08.010 – volume: 24 start-page: 1565 year: 2006 ident: 10.1016/j.ijpx.2022.100120_bb0210 article-title: What is a support vector machine? publication-title: Nat. Biotechnol. doi: 10.1038/nbt1206-1565 – volume: 2 start-page: 422 year: 2018 ident: 10.1016/j.ijpx.2022.100120_bb0055 article-title: 3D printing for chemical, pharmaceutical and biological applications publication-title: Nat. Rev. Chem. doi: 10.1038/s41570-018-0058-y – volume: 13 start-page: 1714 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0020 article-title: Manufacturing and examination of vaginal drug delivery system by FDM 3D printing publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13101714 – year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0135 article-title: Fused deposition modelling 3D printing proof-of-concept study for personalised inner ear therapy publication-title: J. Pharm. Pharmacol. – volume: 16 start-page: 321 year: 2015 ident: 10.1016/j.ijpx.2022.100120_bb0170 article-title: Machine learning applications in genetics and genomics publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3920 – year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0015 – volume: 83 start-page: 9 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0065 article-title: AI applications to medical images: from machine learning to deep learning publication-title: Physica Medica doi: 10.1016/j.ejmp.2021.02.006 – volume: 62 start-page: 1160 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0005 article-title: Emerging landscape of computational modeling in pharmaceutical development publication-title: J. Chem. Inf. Model. doi: 10.1021/acs.jcim.1c01580 – volume: 111 start-page: 116 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0295 article-title: 3D printed intragastric floating and sustained-release tablets with air chambers publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2021.07.010 – volume: 599 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0120 article-title: Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.120417 – volume: 110 start-page: 3150 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0175 article-title: Applications of machine learning in solid oral dosage form development publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2021.04.013 – volume: 597 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0060 article-title: Development of mAb-loaded 3D-printed (FDM) implantable devices based on PLGA publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.120337 – volume: 194 year: 2020 ident: 10.1016/j.ijpx.2022.100120_bb0150 article-title: The role of three-dimensional printing in healthcare and medicine publication-title: Mater. Des. doi: 10.1016/j.matdes.2020.108940 – volume: 564 start-page: 98 year: 2019 ident: 10.1016/j.ijpx.2022.100120_bb0145 article-title: 3D printed oral theophylline doses with innovative ‘radiator-like’ design: impact of polyethylene oxide (PEO) molecular weight publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2019.04.017 – volume: 9 year: 2020 ident: 10.1016/j.ijpx.2022.100120_bb0225 article-title: Additive manufacturing of a point-of-care “Polypill:” fabrication of concept capsules of complex geometry with bespoke release against cardiovascular disease publication-title: Advan. Healthcare Mater. – volume: 167 start-page: 65 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0040 article-title: Influence of the geometry of 3D printed solid oral dosage forms on their swallowability publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2021.07.009 – volume: 109 start-page: 2757 year: 2020 ident: 10.1016/j.ijpx.2022.100120_bb0110 article-title: Fabrication of Mucoadhesive Buccal films for local administration of Ketoprofen and Lidocaine Hydrochloride by Combining Fused Deposition Modeling and Inkjet Printing publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2020.05.022 – volume: 157 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0105 article-title: Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2020.105605 – volume: 567 year: 2019 ident: 10.1016/j.ijpx.2022.100120_bb0200 article-title: Application of artificial neural networks for Process Analytical Technology-based dissolution testing publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2019.118464 – volume: 618 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0180 article-title: Proof of concept of a predictive model of drug release from long-acting implants obtained by fused-deposition modeling publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2022.121663 – volume: 177 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0130 article-title: Polymers in pharmaceutical additive manufacturing: a balancing act between printability and product performance publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2021.113923 – volume: 42 start-page: 745 year: 2021 ident: 10.1016/j.ijpx.2022.100120_bb0095 article-title: Disrupting 3D printing of medicines with machine learning publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2021.06.002 – volume: 28 start-page: 31 year: 2022 ident: 10.1016/j.ijpx.2022.100120_bb0230 article-title: AI in health and medicine publication-title: Nat. Med. doi: 10.1038/s41591-021-01614-0 |
| SSID | ssj0002210389 |
| Score | 2.4517126 |
| Snippet | Three-dimensional printing (3DP) has seen growing interest within the healthcare industry for its ability to fabricate personalized medicines and medical... |
| SourceID | doaj pubmedcentral proquest crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 100120 |
| SubjectTerms | 3D printed drug products and medicines Additive manufacturing of pharmaceuticals Artificial intelligence and digital health Fused filament fabrication and Fused deposition modelling Manufacture of medicinal products Material extrusion and drug delivery systems Printing medical devices and implants Research Paper |
| Title | Accelerating 3D printing of pharmaceutical products using machine learning |
| URI | https://dx.doi.org/10.1016/j.ijpx.2022.100120 https://www.proquest.com/docview/2681443968 https://pubmed.ncbi.nlm.nih.gov/PMC9218223 https://doaj.org/article/266aee1f79734294888a725d5af0554b |
| Volume | 4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYsoKq4vIniT4vaRND36RBb0pOAtpMlk3UW7i67gz3cm6S7tRS_eSpsm6WSS-SadfMPYGUKgwoIpkjr1kBRWycQIWSVgU1wvjRcAdBr54VHePxejF_HSSfVFMWGRHjgK7gINiAFIfVmVOa6dqG_KlJlwwvghmsKaVl-0eR1nahpIXYj4m7Avwvthgk5K2Z6YicFdk-n8G53DLAscRJTsu2OVAnl_zzh1wGc_dLJji-622GYLIvll7Pw2W4Nmh40urUUbQiPajHl-w2nLLlzPPJ-_dreu-TzyvH5yCnsf8_cQUQm8TSEx3mVPd7dP1_dJmykhsUWlFknu8tql0pgCAYl0pbEo9WEtQAIaQe-Ec6l1qrApKK8EcbYXlTSp8FKqEvI9tt7MGthnvELBOqzUCovFnaqlJMa40qsMpLLVgKVLQWnbsohTMos3vQwXm2oSribh6ijcATtfvTOPHBq_lr4i-a9KEv91uIFaoVut0H9pxYCJ5ejpFkpEiIBVTX5t_HQ51BrnGf08MQ3Mvj6xRYW-Z15JNWBlTwd6Pe0_aSavgbG7Ip78LD_4j087ZBvU4RhSc8TWFx9fcIzAaFGfhDlwEnasfgDrzwxY |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accelerating+3D+printing+of+pharmaceutical+products+using+machine+learning&rft.jtitle=International+journal+of+pharmaceutics%3A+X&rft.au=Ong%2C+Jun+Jie&rft.au=Castro%2C+Brais+Mu%C3%B1iz&rft.au=Gaisford%2C+Simon&rft.au=Cabalar%2C+Pedro&rft.date=2022-12-01&rft.issn=2590-1567&rft.eissn=2590-1567&rft.volume=4&rft.spage=100120&rft_id=info:doi/10.1016%2Fj.ijpx.2022.100120&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-1567&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-1567&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-1567&client=summon |